CD8A and chronic myelogenous leukemia, BCR-ABL1 positive: The significantly increased infiltration of CD8+ T cells and the upregulated expression of multiple immune checkpoints in the C1 subtype reconfirmed the existence of significant immunosuppression in CML patients, and such patients may benefit from immunotherapy.